Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for ABSI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 268.92M
March 31, 2026 195.59M
December 31, 2025 216.30M
September 30, 2025 244.99M
June 30, 2025 209.89M
March 31, 2025 232.45M
December 31, 2024 213.61M
September 30, 2024 235.23M
June 30, 2024 255.53M
March 31, 2024 274.90M
December 31, 2023 234.48M
September 30, 2023 236.34M
Date Value
June 30, 2023 254.15M
March 31, 2023 295.81M
December 31, 2022 338.67M
September 30, 2022 339.39M
June 30, 2022 366.32M
March 31, 2022 395.46M
December 31, 2021 426.20M
September 30, 2021 449.12M
June 30, 2021 257.07M
March 31, 2021 222.83M
December 31, 2020 88.57M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Twist Bioscience Corp. 672.44M
Prime Medicine, Inc. 249.04M
Tenax Therapeutics, Inc. 121.66M
Exicure, Inc. 11.40M
Recursion Pharmaceuticals, Inc. 1.213B

Total Assets (Quarterly) Related Metrics